FDA Will Crack Down On GMP Ingredient, Contaminant Spec Requirements
This article was originally published in The Tan Sheet
Executive Summary
GMP inspectors will begin more aggressively enforcing requirements for ingredient and contaminant specifications, FDA’s Fabricant warns. Recalls for undeclared allergens, salmonella and other pathogens are emerging more frequently as well.
You may also be interested in...
More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
FDA supplement program official Daniel Fabricant says firms that fail to use appropriate tests for botanical ingredients are at risk of eliciting warning letters and other agency actions for violating GMPs. AHP’s Roy Upton says he sees FDA’s botanical expertise outpacing industry’s.
More GMP Warnings Likely As Botanicals Fail On Adulteration Awareness
FDA supplement program official Daniel Fabricant says firms that fail to use appropriate tests for botanical ingredients are at risk of eliciting warning letters and other agency actions for violating GMPs. AHP’s Roy Upton says he sees FDA’s botanical expertise outpacing industry’s.
FDA Will Peel Back Another Layer Of GMP Compliance In 2013
FDA will take GMP inspections beyond the basics in 2013, experts agree. Firms can expect more inspections, deeper dives from reviewers and tougher consequences.